Exclusive agreements between Federal agencies and Bristol-Myers Squibb Co. for drug development
Subtitle: is the public interest protected? : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, first session, Washington, DC, July 29, 1991.
Publisher: U.S. G.P.O.; For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Published: 1992
Place of publication: Washington
Language: eng
Number of pages: 503
Subjects: Bristol-Myers Squibb Company.; Administrative agencies -- United States.; Exclusive contracts -- United States.; Paclitaxel.; Pacific yew -- Northwest, Pacific.; Cancer -- Treatment -- Research -- United States.
Notes: Includes bibliographical references.
Item 1031-A, 1031-B (MF)
Distributed to some depository libraries in microfiche.
Shipping list no. 92-178-P.
"Serial no. 102-35."